Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Oratie: ‘Revolutie op komst in behandeling neurodegeneratieve ziekten’
mrt 2022 | Bewegingsstoornissen, Dementie, Neuro-musculair